|Bid||19.70 x 0|
|Ask||19.78 x 0|
|Day's Range||18.88 - 19.89|
|52 Week Range||6.31 - 24.75|
|PE Ratio (TTM)||109.44|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||18.31|
The energy sector pushed Canada's main stock index up on Friday, as oil prices rose on supply concerns ahead of a meeting of OPEC and other large crude exporters. * The energy sector climbed 1.1 percent ...
LEAMINGTON, ON , Sept. 21, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has appointed John Sadler as the Company's Vice President of Investor Relations effective September 15, 2018 . Mr. Sadler brings more than 25 years of capital markets expertise to his new role at Aphria where he will be responsible for managing all of the Company's interactions with its institutional and retail equity investors as well as the sell-side analysts who publish research on the Company.
LEAMINGTON, ON , Sept. 20, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that its Australian-based partner Althea Company Pty Ltd. ("Althea" or the "Australian Company") has successfully completed the fund raising for its proposed listing on the Australian Securities Exchange ("ASX") via an Initial Public Offering ("IPO"). Demand for shares in Althea significantly exceeded the proposed maximum fund raising under the IPO of AUD$19.65 million. Aphria took a cornerstone position in the IPO by subscribing for an additional 17 million shares which has resulted in a 25% holding in Althea (AUD$3.4 million investment).
LEAMINGTON, ON , Sept. 20, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced they have signed supply agreements with official distributors in all ten provinces and one territory to provide high-quality, branded cannabis products for the adult-use market across the country come recreational cannabis legalization on October 17 th. With 28 days to legalization, Aphria has already begun shipping initial product orders to ensure an extensive range of products from the Company's expanding portfolio of adult-use brands will be available to consumers on October 17. Aphria's recreational brands Solei and RIFF will also be available through online and in-store retailers in all markets.
Shareholders Approve Name Change to SOL Investments Corp. TORONTO, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (CSE:SCYB) (9SB.F) (OTC – Nasdaq Intl: SCCYF) is pleased to announce the results of Scythian’s special meeting of shareholders on September 14, 2018 (“Special Meeting”).
LEAMINGTON, ON , Sept. 14, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that Dennis Staudt has resigned from the Company's Board of Directors (the "Board"). Mr. Staudt served as Lead Independent Director and Chair of the Audit Committee, and he had been a member of the Board since 2014, before the company was publicly traded.
* U.S. crude prices were down 0.7 percent a barrel, while Brent crude lost 0.7 percent. * Only four of the index's 11 major sectors were higher, led by the information technology sector's 0.7 percent rise. * Shopify, Celestica and Evertz Technologies gained between 0.7 percent and 2 percent and lifted the technology sector.
Canada's main stock index dipped on Thursday after shares of Canadian discount store chain Dollarama plunged after posting disappointing quarterly results and weighed on the consumer discretionary sector. ...
TORONTO/LONDON (Reuters) - A favourite of DIY stock pickers, Canadian cannabis firms are trying to bolster their institutional investor base by ramping up efforts to woo European funds as countries across the region approve marijuana for medical use. For some time companies including Canopy Growth (WEED.TO), Aurora Cannabis (ACB.TO) and Tilray Inc (TLRY.O) have been signing export deals with European governments, buying local companies, even opening production facilities in the region. This year, they have also stepped up pitching their businesses to European funds at conferences and road shows, betting their size and first-mover advantage will help replace fickle retail investors with more stable institutions.
Canada in particular is the focus as of late with a number of Canadian cannabis stocks benefiting in a big way from new highs in the market. According to estimates by cannabis researchers at ArcView Market Research in partnership with BDS Analytics, the latest revenue projections for the U.S. medical cannabis industry in 2018 is $4.3 billion versus $6.7 billion for adult use. Last year, medical marijuana sales came in just under $6 billion while adult use grabbed $2.6 billion.
LEAMINGTON, ON , Sept. 12, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has entered into a wholesale supply agreement with Emblem Cannabis Corp., wholly owned subsidiary of Emblem Corp. and a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations ("Emblem") to supply 175,000 kg of high-quality cannabis over a five-year period starting May 2019 (the "Agreement") with a total of 25,000 kg deliverable for the balance of the first year. Under the terms of the Agreement, Aphria will receive a non-refundable deposit of $22.8 million , which is comprised of $12.8 million in cash, and 6,952,169 of common shares of Emblem. "Aphria's total annualized production capabilities are about to reach 255,000kg in early 2019, which means we are not only well positioned to meet all of our supply commitments across Canada and anticipated international demand, but also have the capacity to support the projected demand through our partners," said Gregg Battersby , Vice President of Commercial Strategy at Aphria.
The legalization of cannabis is taking hold on a global scale and even CEO's like Tesla's (TSLA) Elon Musk appear to be taking a liking to new legislation. Investors are now looking to Canadian marijuana stocks as these have continued to reach new milestones over recent months. With the industry expecting continued to grow after Oct. 17, when weed will become legal across Canada for any purpose, a number of investors are looking to get a piece of the action.
Canada's main stock index rose on Thursday on optimism of a revised North American Free Trade Agreement as top U.S. and Canadian trade negotiators were set for a second day of talks. * Canadian Foreign Minister Chrystia Freeland sounded sanguine on Wednesday as she emerged from negotiations with top U.S. trade negotiator Robert Lighthizer, although she cautioned that no trade deal was done until the last issue was nailed down. * At 9:41 a.m. ET (13:41 GMT), the Toronto Stock Exchange's S&P/TSX composite index was up 9.09 points, or 0.06 percent, at 16,146.66.
LEAMINGTON, ON , Sept. 6, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has entered into a share purchase agreement with a group of buyers, each acting individually and not in concert, including a member of the Serruya family, and has completed the sale of 64,118,462 shares (the "Shares") in Liberty Health Sciences, Inc. ("Liberty"), representing 100% of the Company's outstanding investment in Liberty. As part of the transaction, Aphria retains an irrevocable option to repurchase the Shares or any replacement securities from the buyers for a period of up to five years, subject to the satisfaction of certain conditions as further described below.
The additional flowering rooms will increase total potential flowering capacity to 90,000 square feet and, assuming a current yield, will bring 7ACRES' annual production potential from 10,000kg to 13,330kg. "As the first coast-to-coast premium cannabis brand in Canada , 7ACRES is already one of the fastest scaling producers in the country. This flowering room expansion continues to increase our capacity and improve our ability to meet the demand of cannabis enthusiasts upon legalization of adult use cannabis in Canada ," said John Fowler , CEO of Supreme Cannabis. Completion of flowering rooms at the 342,000-square foot 7ACRES facility remains on schedule for completion in December 2018. With an annual production capacity expected to reach 50,000 kg once the 7ACRES facility is fully operational, the Company is committed to supplying premium-quality cannabis flower to the Canadian recreational market from coast-to-coast.
LEAMINGTON , ON and BURLINGTON, ON , Sept. 5, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) and Rapid Dose Therapeutics Inc. ("RDT"), a Canadian bio-technology company focused on innovative drug delivery solutions, announced today that they have signed a non-binding Memorandum of Understanding ("MOU") related to RDT's QuickStrip™ products. Under the terms of the MOU, the companies intend to enter into a definitive agreement in the near future pursuant to which RDT will provide Aphria with exclusive global preferred rights to produce, distribute and sell QuickStrip™ products for cannabis markets around the world.
Marijuana-related stocks rampaged higher Tuesday, after Cronos Group Inc. detailed an agreement that seeks to extract key compounds from cannabis for medicinal purposes.
LEAMINGTON, ON , Sept. 4, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has entered into a strategic partnership (the "Partnership") with Schroll Medical ('Schroll" or the "Danish Company"), a subsidiary of prominent European flower producer, Schroll Flowers. The Partnership will pursue the cultivation and worldwide distribution of organic, EU GMP-certified medical cannabis, and will be managed by the Company's wholly-owned subsidiary Aphria Deutschland GmbH ("Aphria Germany").
Canada's main stock index slipped on Friday following a report that a North American Free Trade Agreement deal with the United States might not be concluded by the end of the day. * At 9:38 a.m. ET , the ...
NEW YORK, NY / ACCESSWIRE / August 31, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...
Optimism about reaching a new NAFTA deal by the end of this week lifted Canada's main index on Thursday and energy companies provided a boost as oil prices rose. * Talks between Canada and the United States ...
Canada's main stock index rose on Wednesday as the country's top trade negotiator continued talks to preserve a three-nation NAFTA trade pact following Monday's deal. * At 10:01 a.m. ET , the Toronto Stock ...
LEAMINGTON, ON , Aug. 27, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has entered into a supply agreement (the "Agreement") with the Nova Scotia Liquor Corporation ("NSLC") to provide a range of high-quality branded cannabis and cannabis derivative products for sale in Nova Scotia's adult-use market starting on October 17, 2018 .
A cannabis-related ETF was among leaders in the markets Monday as Canadian pot stocks rallied amid rising speculation that more alcohol companies will be partnering up with marijuana growers in response ...